XL999 Administered Intravenously to a Subject With Advanced Malignancies
NCT01945164
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
OTHER
Sponsor class
Conditions
Advanced Malignancy
Interventions
DRUG:
XL999
Sponsor
John Sarantopoulos